Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism. - Wikidata - awgldk - TriplyDB

Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

http://www.wikidata.org/entity/Q33574947

about

Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2 Boronic acid-containing CXCR1/2 antagonists: Optimization of metabolic stability, in vivo evaluation, and a proposed receptor binding model Inhibition of Human Neutrophil Responses by the Essential Oil of Artemisia kotuchovii and Its Constituents.Boronic acid-containing aminopyridine- and aminopyrimidinecarboxamide CXCR1/2 antagonists: Optimization of aqueous solubility and oral bioavailability.Pharmacological modulation of chemokine receptor function.Targeting chemokines in proteinuria-induced renal disease.

P2860

Q34394197-8562A947-723F-4C75-8FA9-BDCE2DBC5B1F Q35602485-CD3907BA-457F-438B-9870-A1BD1EE80531 Q35775743-2B80DA62-17EA-44EF-9761-B0A1081379F0 Q36041334-A79747CA-28EA-4665-AF2F-D25956995484 Q37893687-2337B4E9-5E02-4E85-9C7A-0203DE1FFCBF Q38026076-9B6E97F4-B67A-4BAC-A21A-8A724602135D

P2860

Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

http://www.wikidata.org/entity/Q33574947

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

@ast

Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

@en

Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

@nl

type

label

Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

@ast

Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

@en

Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

@nl

prefLabel

Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

@ast

Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

@en

Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

@nl

P1433

Q33574947-D8207A32-5B47-4A1C-BF3C-A9CA75B63C34

P1476

Q33574947-7410F077-6941-4268-ACE1-BABA606B2680

P2093

Q33574947-173569CB-19DB-4142-A760-6FE87D639088

Q33574947-1E719E93-09DC-4F1A-83B9-564F14BE2AA2

Q33574947-22E7A054-40E0-45A0-8AA2-6874F9586783

Q33574947-85582921-F08B-4967-B40F-038276B2CD5B

Q33574947-CFAE7273-5F93-47F3-ADA8-05F6AE18FD79

P2860

Q33574947-07220624-4BFF-4917-8C10-9C5AB5D50EBC

Q33574947-2C57D898-F349-4DE8-A13C-FFF872115092

Q33574947-31F40737-0381-43DA-8CFC-03B46FF48B65

Q33574947-36BF5B37-1061-41C6-8BE5-7A44DBBFAC38

Q33574947-3DDAA927-BC42-4E32-98C9-CC1EFAF84A5B

Q33574947-4244EC78-58DE-44FA-8349-F9F2DB122424

Q33574947-5BEFB0E4-B745-48AF-AAA7-449E12CDE729

Q33574947-61DD2226-B2DD-4502-B742-52B64D6A609F

Q33574947-6B9F1598-E680-4E1D-ADE6-57BBDD4F1AF2

Q33574947-78B32704-38A4-48C6-96F7-8AABEBC73B41

P304

Q33574947-C3B14DD2-1AB1-4212-8F0B-1C7E6CF95FDC

P31

Q33574947-3796E8E3-4335-4855-8D1F-B1DFDFD69455

P356

Q33574947-0A4F2BC9-E0BF-4609-B2FF-AB2D2A63218B

P407

Q33574947-9D48A1ED-CABD-41C6-BEF0-6F973968F51A

P433

Q33574947-821F9795-D088-404D-B426-85916FC8B14C

P478

Q33574947-0CF73177-A97F-4759-8DB1-098D7E3510DE

P577

Q33574947-2906C2D7-AEC9-4A93-B9D3-F7E0BC4361C6

P5875

Q33574947-668304D0-45FE-42E8-B0FE-3FD11A280BDE

P698

Q33574947-02A5EC5B-1161-4DDC-ADB6-C7AFAD54F871

P932

Q33574947-414C81A9-ACEB-4B49-8B5B-4B7352A9B20B

P356

JPET.109.159020

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Nicotinamide glycolates antagonize CXCR2 activity through an intracellular mechanism.

@en

P2093

Dean Y Maeda

http://www.w3.org/2001/XMLSchema#string

Igor A Schepetkin

http://www.w3.org/2001/XMLSchema#string

John A Zebala

http://www.w3.org/2001/XMLSchema#string

Liliya N Kirpotina

http://www.w3.org/2001/XMLSchema#string

Mark T Quinn

http://www.w3.org/2001/XMLSchema#string

P2860

Structure and functional expression of a human interleukin-8 receptor

Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2

Chemokine: receptor structure, interactions, and antagonism

Cloning of complementary DNA encoding a functional human interleukin-8 receptor

Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2

Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.

Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist.

ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.

CXCR2 antagonists for the treatment of pulmonary disease.

Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury.

P304

145-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.109.159020

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

332

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26836111

http://www.w3.org/2001/XMLSchema#string

P698

19779130

http://www.w3.org/2001/XMLSchema#string

P932

2802484

http://www.w3.org/2001/XMLSchema#string